Is RYZB or VYM a better dividend investment in 2026?

RYZB currently yields 3.20% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: RYZB offers higher current income.

What is the dividend yield difference between RYZB and VYM?

RYZB has a forward dividend yield of 3.20% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 0.79 percentage points.

Home › Compare › RYZB vs VYM

RYZB vs VYM: Dividend Comparison 2026

RYZB yields 3.20% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VYM wins by $3.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RYZB

● Live price

3.20%

Share price

$62.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.6K

Annual income

$393.29

Full RYZB calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — RYZB vs VYM

📍 VYM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RYZB	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RYZB + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RYZB pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYZB

Annual income on $10K today (after 15% tax)

$272.04/yr

After 10yr DRIP, annual income (after tax)

$334.30/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, RYZB beats the other by $97.53/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYZB + VYM for your $10,000?

RYZB: 50%VYM: 50%

100% VYM50/50100% RYZB

Portfolio after 10yr

$26.2K

Annual income

$335.92/yr

Blended yield

1.28%

📊

Analyst Conviction Gap

Where Wall Street is split right now

RYZB

Analyst Ratings

Hold

Consensus: Hold

VYM

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYZB buys

VYM buys

Politician	Chamber	Ticker	Type	Amount	Date
Carol Devine Miller	🏢 House	$VYM	▲ Buy	$15,001 - $50,000	2022-11-02

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRYZBVYM

Forward yield	3.20% ✓	2.41%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$24.6K	$27.8K ✓
Annual income after 10y	$393.29 ✓	$278.55
Total dividends collected	$3.6K ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RYZB vs VYM ($10,000, DRIP)

Year	RYZB Portfolio	RYZB Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$11,020	$320.05	$11,151	$241.44	$131.00 → VYM
2	$12,121	$329.62	$12,413	$246.79	$292.00 → VYM
3	$13,308	$338.84	$13,794	$251.79	$486.00 → VYM
4	$14,588	$347.69	$15,306	$256.47	$718.00 → VYM
5	$15,965	$356.18	$16,960	$260.84	$995.00 → VYM
6	$17,447	$364.31	$18,768	$264.92	$1.3K → VYM
7	$19,040	$372.08	$20,745	$268.71	$1.7K → VYM
8	$20,753	$379.49	$22,905	$272.24	$2.2K → VYM
9	$22,592	$386.56	$25,265	$275.51	$2.7K → VYM
10	$24,566	$393.29	$27,842	$278.55	$3.3K → VYM

RYZB vs VYM: Complete Analysis 2026

RYZB — Stock

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company’s lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.

Full RYZB Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this RYZB vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYZB vs SCHD RYZB vs JEPI RYZB vs O RYZB vs KO RYZB vs MAIN RYZB vs VIG RYZB vs DGRO RYZB vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.